Skip to main content

Advertisement

Log in

Molecular fingerprinting of Staphylococcus aureus from bone and joint infections

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The objective of the study was to determine if a clonal complex (CC) of Staphylococcus aureus or certain virulence and adhesion factors were associated with infections of bones and prosthetic implants. One hundred and nineteen isolates were characterised using microarrays. There was no evidence for a single virulence factor or CC being causative for bone and implant infections. Isolates belonged to 20 different CCs, with CC8 (19.33%), CC45 (17.65%) and CC30 (12.61%) being dominant. Population structure and the relative abundances of virulence genes was similar to previously described isolates from healthy carriers. Differences to carrier isolates included a higher proportion of CC45, a lower proportion of CC15, as well as a higher abundance of sak (staphylokinase) among patient isolates. For 23 patients with infections of total knee or hip prosthetics, it was possible to simultaneously obtain nasal swabs. Fifteen (65.2%) carried S. aureus in their anterior nares. In nine of them (39.1%), isolates from the infection site were identical to carriage isolates. This suggests an elevated risk of infection for S. aureus carriers and the possibility of endogenous infection in a high proportion of them. Therefore, the pre-operative screening and eradication of S. aureus in patients receiving total joint prosthetics should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sourek J, Výmola F, Trojanová M, Zelenková L, Matĕjovska V, Bergdoll MS (1979) Enterotoxin production by Staphylococcus aureus strains isolated from cases of chronic osteomyelitis. J Clin Microbiol 9:266

    CAS  PubMed  Google Scholar 

  2. Cunningham R, Cockayne A, Humphreys H (1996) Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol 44:157

    Article  CAS  PubMed  Google Scholar 

  3. Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, Vanhems P, Floret D, Etienne J (2007) Pediatric bone and joint infections caused by Panton–Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 26:1042

    Article  PubMed  Google Scholar 

  4. Clarke SR, Foster SJ (2006) Surface adhesins of Staphylococcus aureus. Adv Microb Physiol 51:187

    Article  CAS  PubMed  Google Scholar 

  5. Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16

    Article  CAS  PubMed  Google Scholar 

  6. Kaneko J, Kamio Y (2004) Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68:981

    Article  CAS  PubMed  Google Scholar 

  7. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME (2008) Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 52:13

    Article  CAS  PubMed  Google Scholar 

  8. Swingle EL (1935) Studies on small colony variants of Staphylococcus aureus. J Bacteriol 29:467

    CAS  PubMed  Google Scholar 

  9. Proctor RA, Balwit JM, Vesga O (1994) Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis 3:302

    CAS  PubMed  Google Scholar 

  10. von Eiff C, Bettin D, Proctor RA, Rolauffs B, Lindner N, Winkelmann W, Peters G (1997) Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 25:1250

    Article  Google Scholar 

  11. von Eiff C, Proctor RA, Peters G (2000) Staphylococcus aureus small colony variants: formation and clinical impact. Int J Clin Pract Suppl 44

  12. Brandt CM, Duffy MC, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR (1999) Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 74:553

    Article  CAS  PubMed  Google Scholar 

  13. Monecke S, Jatzwauk L, Weber S, Slickers P, Ehricht R (2008) DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from Eastern Saxony. Clin Microbiol Infect 14:534

    Article  CAS  PubMed  Google Scholar 

  14. Monecke S, Slickers P, Ehricht R (2008) Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol 53:237–251

    Article  CAS  PubMed  Google Scholar 

  15. Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008

    CAS  PubMed  Google Scholar 

  16. Robinson DA, Enright MC (2004) Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol 186:1060

    Article  CAS  PubMed  Google Scholar 

  17. Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a University Hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442

    Article  CAS  PubMed  Google Scholar 

  18. Monecke S, Luedicke C, Slickers P, Ehricht R (2009) Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis 28:1159

    Article  CAS  PubMed  Google Scholar 

  19. Monecke S, Slickers P, Ellington M, Kearns A, Ehricht R (2007) High diversity of Panton–Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus. Clin Microbiol Infect 13:1157

    Article  CAS  PubMed  Google Scholar 

  20. Bokarewa MI, Jin T, Tarkowski A (2006) Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol 38:504

    Article  CAS  PubMed  Google Scholar 

  21. van Wamel WJB, Rooijakkers SHM, Ruyken M, van Kessel KPM, van Strijp JAG (2006) The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on {beta}-hemolysin-converting bacteriophages. J Bacteriol 188:1310

    Article  PubMed  Google Scholar 

  22. Coleman D, Knights J, Russell R, Shanley D, Birkbeck TH, Dougan G, Charles I (1991) Insertional inactivation of the Staphylococcus aureus beta-toxin by bacteriophage phi 13 occurs by site- and orientation-specific integration of the phi 13 genome. Mol Microbiol 5:933

    Article  CAS  PubMed  Google Scholar 

  23. Coleman DC, Sullivan DJ, Russell RJ, Arbuthnott JP, Carey BF, Pomeroy HM (1989) Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion. J Gen Microbiol 135:1679

    CAS  PubMed  Google Scholar 

  24. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton–Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128

    Article  CAS  PubMed  Google Scholar 

  25. Larson EL, Hughes CA, Pyrek JD, Sparks SM, Cagatay EU, Bartkus JM (1998) Changes in bacterial flora associated with skin damage on hands of health care personnel. Am J Infect Control 26:513

    Article  CAS  PubMed  Google Scholar 

  26. van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HFL, Verbrugh HA (2009) Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9:32

    Article  PubMed  Google Scholar 

  27. Crossley K (2009) Review: intranasal mupirocin ointment reduces Staphylococcus aureus infections in nasal carriers. Evid Based Med 14:110

    Article  PubMed  Google Scholar 

  28. van Rijen M, Bonten M, Wenzel R, Kluytmans J (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev CD006216

Download references

Acknowledgements

The authors thank A. Ruppelt, H. Kanig, S. Kolewa, E. Müller, I. Engelmann and J. Sachtschal for their excellent technical assistance, as well as R. Schuster and T. Uhlig for developing the software used in the microarray analysis. We acknowledge Prof. E. Jacobs, Prof. G. Ehninger and E. Ermantraut for their support. We thank D. Rowe and W. Rudolph for critically reading the manuscript.

The study was funded by the Vice-Directorate for Research of the Faculty of Medicine “Carl Gustav Carus” (MedDrive program 2008).

Ralf Ehricht and Peter Slickers are employees of CLONDIAG.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Monecke.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM. 1

(PDF 410 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luedicke, C., Slickers, P., Ehricht, R. et al. Molecular fingerprinting of Staphylococcus aureus from bone and joint infections. Eur J Clin Microbiol Infect Dis 29, 457–463 (2010). https://doi.org/10.1007/s10096-010-0884-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-010-0884-4

Keywords

Navigation